Weight-loss drug developer Metsera targets up to $1.78 billion valuation in US IPO

#WeightLossDrugs | #BiotechIPO | #USIPO | #GLP1Drugs  | #ObesityTreatment | #HealthcareInnovation |  #InvestmentNews | #BiotechIndustry
Read more: